Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...

BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Erectile Dysfunction Drugs Market 2025 The global market is driven by factors such as an Increase in the prevalence of erectile dysfunction ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Buying Cialis online can be simple and affordable. Here, we explore the five best platforms offering generic and branded Cialis based on medication price, ease of use, and our testers’ experiences.

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile dysfunction ...

Opella said that the FDA lifted the clinical hold on its actual use trial (AUT), which it has planned to support a potential switch of Cialis tablets from a prescription-only medicine to an over ...

Prescription Cialis was first approved in 2003 and is marketed by Eli Lilly. In 2014, Lilly inked a licensing agreement with Sanofi that allows the latter company to pursue regulatory approval of ...